References
Tafuri A, Ashrafi AN, Palmer S, Shakir A, Cacciamani GE, Iwata A, Iwata T, Cai J, Sali A, Gupta C, Medina LG, Stern MC, Duddalwar V, Aron M, Gill IS, Abreu A (2019) One-stop MRI and MRI/transrectal ultrasound fusion-guided biopsy: an expedited pathway for prostate cancer diagnosis. World J Urol. https://doi.org/10.1007/s00345-019-02835-2
Bass EJ, Freeman A, Jameson C, Punwani S, Moore CM, Arya M, Emberton M, Ahmed HU (2018) Prostate cancer diagnostic pathway: is a one-stop cognitive MRI targeted biopsy service a realistic goal in everyday practice? A pilot cohort in a tertiary referral centre in the UK. BMJ Open 8(10):e024941. https://doi.org/10.1136/bmjopen-2018-024941
Auer T, Edlinger M, Bektic J, Nagele U, Herrmann T, Schafer G, Aigner F, Junker D (2017) Performance of PI-RADS version 1 versus version 2 regarding the relation with histopathological results. World J Urol 35(5):687–693. https://doi.org/10.1007/s00345-016-1920-5
De Visschere P, Lumen N, Ost P, Decaestecker K, Pattyn E, Villeirs G (2017) Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA. Clin Radiol 72(1):23–32. https://doi.org/10.1016/j.crad.2016.09.011
Di Campli E, Delli Pizzi A, Seccia B, Cianci R, d’Annibale M, Colasante A, Cinalli S, Castellan P, Navarra R, Iantorno R, Gabrielli D, Buffone A, Caulo M, Basilico R (2018) Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: comparison between readers with different experience. Eur J Radiol 101:17–23. https://doi.org/10.1016/j.ejrad.2018.01.028
Kuhl CK, Bruhn R, Kramer N, Nebelung S, Heidenreich A, Schrading S (2017) Abbreviated biparametric prostate MR Imaging in men with elevated prostate-specific antigen. Radiology 285(2):493–505. https://doi.org/10.1148/radiol.2017170129
Junker D, Steinkohl F, Fritz V, Bektic J, Tokas T, Aigner F, Herrmann TRW, Rieger M, Nagele U (2018) Comparison of multiparametric and biparametric MRI of the prostate: are gadolinium-based contrast agents needed for routine examinations? World J Urol. https://doi.org/10.1007/s00345-018-2428-y
Author information
Authors and Affiliations
Contributions
T Tokas: manuscript writing. D Junker: manuscript editing. U Nagele: manuscript editing.
Corresponding author
Ethics declarations
Conflicts of interest
No conflicts of interest.
Human and animal rights
This letter does not involve human participants and/or animals.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Tokas, T., Junker, D. & Nagele, U. One-stop biparametric MRI and MRI/ultrasound fusion-guided biopsy: can we include the histopathology result and our treatment recommendations in our diagnostic pathway?. World J Urol 38, 2067–2068 (2020). https://doi.org/10.1007/s00345-019-02940-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-019-02940-2